Acrivon Therapeutics Inc....

5.34
0.03 (0.56%)
At close: Mar 03, 2025, 12:45 PM

Acrivon Therapeutics Common Stock Balance Sheet Statement

Year FY23 FY22 FY21 FY20
Cash & Equivalents 36.02M 29.52M 99.6M 1.58M
Short-Term Investments 91.44M 98.23M n/a n/a
Long-Term Investments 414K 41.88M 388K 407K
Other Long-Term Assets 251K 4.73M n/a n/a
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 2.23M 4.34M 805K 136K
Total Current Assets 129.69M 127.75M 100.41M 1.72M
Property-Plant & Equipment 7.91M 6.86M 5.79M 59K
Goodwill & Intangibles n/a n/a n/a n/a
Total Long-Term Assets 8.57M 53.48M 6.18M 466K
Total Assets 138.26M 181.23M 106.59M 2.19M
Account Payables 5.05M 904K 964K 136K
Deferred Revenue n/a 69K 66K n/a
Short-Term Debt 877K 1.45M 664K 58K
Other Current Liabilities 7.38M 4.09M 1.22M 419K
Total Current Liabilities 13.3M 6.52M 2.91M 613K
Long-Term Debt 3.77M 4.24M 4.96M n/a
Other Long-Term Liabilities n/a n/a 122.52M n/a
Total Long-Term Liabilities 3.77M 4.24M 127.48M 9.98M
Total Liabilities 17.07M 10.75M 130.4M 10.6M
Total Debt 4.64M 4.96M 5.63M 58K
Common Stock 23K 22K 2K 1K
Retained Earnings -116.42M -56.03M -24.86M -8.62M
Comprehensive Income -83K -95K n/a n/a
Shareholders Equity 121.19M 170.47M -23.81M -8.41M
Total Investments 91.86M 140.11M 388K 407K